Web Results

en.wikipedia.org/wiki/Drotrecogin_alfa

Drotrecogin alfa (activated) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties.

www.ncbi.nlm.nih.gov/pmc/articles/PMC1276518

Drotrecogin alfa (activated) (Xigris, Eli Lilly and Company, Indianapolis, Ind) is a recombinant form of human activated protein C. It was approved by the Food ...

www.nejm.org/doi/full/10.1056/NEJMoa1202290

May 22, 2012 ... Original Article from The New England Journal of Medicine — Drotrecogin Alfa ( Activated) in Adults with Septic Shock.

www.drugs.com/cdi/drotrecogin-alfa.html

Easy to read patient leaflet for drotrecogin alfa. Includes indications, proper use, special instructions, precautions, and possible side effects.

www.rxlist.com/xigris-drug.htm

Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. An established human cell line possessing the complementary DNA for ...

www.medscape.com/viewarticle/752169

Oct 25, 2011 ... October 25, 2011 — Eli Lilly is withdrawing activated drotrecogin alfa (Xigris), a drug intended to treat severe sepsis in high-risk patients, from ...

www.fda.gov/Drugs/DrugSafety/ucm277114.htm

Oct 25, 2011 ... FDA Drug Safety Communication: Voluntary market withdrawal of Xigris [ drotrecogin alfa (activated)] due to failure to show a survival benefit.

www.clevelandclinicmeded.com/medicalpubs/pharmacy/janfeb2002/drotrecogin.htm

Drotrecogin alfa [recombinant Human Activated Protein C (Xigris™)], was recently approved by the FDA for the reduction of mortality in adult patients with severe ...

www.emedicinehealth.com/drug-drotrecogin_alfa/article_em.htm

Drug information on Xigris (drotrecogin alfa), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.